Upload Avatar (500 x 500)
Yujie Shi
yujiestone@bjmu.edu.cn
Chinese, English
Beijing
Peking University
Pharmaceutical Sciences
  • 2013/09-2016/07 PhD in Pharmaceutics: Peking University
  • 2002/09-2005/07 Master's in Pharmaceutical Analysis: Peking University
  • 1995/09-1999/07 Bachelor's in Pharmaceutical Preparation: China Pharmaceutical University
  • 2005-present - Peking University - Lecturer and Researcher
New Nano Drug Delivery Systems
New Techniques and Methods in Pharmaceutical Analysis
  • The interactions of single-wall carbon nanohorns with polar epithelium, Yujie Shi, Zujin Shi, Suxin Li, Yuan Zhang, Bing He, Dong Peng, Jie Tian, Ming Zhao, Xueqing Wang, Qiang Zhang, 2017
  • Novel Biological Functions of ZIF-NP as a Delivery Vehicle: High Pulmonary Accumulation, Favorable Biocompatibility and Improved Therapeutic Outcome, Suxin Li, Keke Wang, Yujie Shi, Yanan Cui, Binlong Chen, Bing He, Wenbing Dai, Hua Zhang, Xueqing Wang, Chongli Zhong, Hounan Wu, Qingyuan Yang, Qiang Zhang, 2016
  • The Development of Site-specific Drug Delivery Nanocarriers Based on Receptor Mediation, Xueqing Wang, Suxin Li, Yujie Shi, Xingxing Chuan, Ji Li, Ting Zhong, Hua Zhang, Wenbing Dai, Bing He, Qiang Zhang, 2014
  • Nuclear TAR DNA-binding protein 43: A new target for amyotrophic lateral sclerosis treatment, Zheng Mei, Shi Yujie, Fan Dongsheng, 2013
  • Isolation of lipids from photosystem I complex and its characterization with high performance liquid chromatography/electrospray ionization mass spectrometry, Hongjun Yao, Yujie Shi, Rongfu Gao, Guifeng Zhang, Rumin Zhang, Caixia Zheng, Bingjiu Xu, 2006
  • Enantioseparation of 2-O-b-d-glucopyranosyl-2H-1, 4-benzoxazin-3(4H)-one and its 7-chloro-derivative by capillary zone electrophoresis using native and substituted b-cyclodextrins as chiral additives, Shi Yujie, Huo Changhong, Yao Hongjun, Gao Rongfu, Zhao Yuying, Xu Bingjiu, 2005
Nano Drug Delivery Pharmaceutical Analysis Nanotechnology Drug Delivery Systems Biomedical Research Analytical Chemistry Pharmacokinetics Drug Formulation Therapeutic Outcomes Biocompatibility

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.